PT93991A - Processo para a preparacao de solucoes estaveis de analogos de rebecamicina - Google Patents

Processo para a preparacao de solucoes estaveis de analogos de rebecamicina

Info

Publication number
PT93991A
PT93991A PT93991A PT9399190A PT93991A PT 93991 A PT93991 A PT 93991A PT 93991 A PT93991 A PT 93991A PT 9399190 A PT9399190 A PT 9399190A PT 93991 A PT93991 A PT 93991A
Authority
PT
Portugal
Prior art keywords
rebeccamycin
acid
stable solutions
rebecamycinal
analogs
Prior art date
Application number
PT93991A
Other languages
English (en)
Other versions
PT93991B (pt
Inventor
Ubrani V Venkataram
Miriam K Franchini
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT93991A publication Critical patent/PT93991A/pt
Publication of PT93991B publication Critical patent/PT93991B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
PT93991A 1989-05-10 1990-05-09 Processo para a preparacao de solucoes estaveis de analogos de rebecamicina PT93991B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (2)

Publication Number Publication Date
PT93991A true PT93991A (pt) 1991-02-08
PT93991B PT93991B (pt) 1996-11-29

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93991A PT93991B (pt) 1989-05-10 1990-05-09 Processo para a preparacao de solucoes estaveis de analogos de rebecamicina

Country Status (25)

Country Link
US (1) US5496809A (pt)
EP (1) EP0397147B1 (pt)
JP (1) JPH0643437B2 (pt)
KR (1) KR920004098B1 (pt)
CN (1) CN1054510C (pt)
AT (1) ATE117313T1 (pt)
AU (1) AU618896B2 (pt)
CA (1) CA2015632C (pt)
CZ (1) CZ283416B6 (pt)
DE (1) DE69016087T2 (pt)
DK (1) DK0397147T3 (pt)
EG (1) EG19218A (pt)
ES (1) ES2066902T3 (pt)
FI (1) FI95777C (pt)
GR (1) GR3015714T3 (pt)
HK (1) HK1005033A1 (pt)
HU (1) HU206627B (pt)
IE (1) IE66515B1 (pt)
IL (1) IL94312A (pt)
NO (1) NO176390C (pt)
PT (1) PT93991B (pt)
RU (1) RU2053766C1 (pt)
TW (1) TW202390B (pt)
YU (1) YU90490A (pt)
ZA (1) ZA903535B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125976T3 (es) * 1992-03-20 1999-03-16 Wellcome Found Otros derivados de indol con accion antiviral.
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
WO1998019707A1 (en) * 1996-11-05 1998-05-14 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (en) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Polymeric material having a cloth-like appearance
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
IL94312A (en) 1994-02-27
IL94312A0 (en) 1991-03-10
KR920004098B1 (ko) 1992-05-25
FI95777B (fi) 1995-12-15
EP0397147B1 (en) 1995-01-18
CN1047204A (zh) 1990-11-28
HU902989D0 (en) 1990-09-28
FI95777C (fi) 1996-03-25
HUT54053A (en) 1991-01-28
NO176390C (no) 1995-03-29
ZA903535B (en) 1991-01-30
RU2053766C1 (ru) 1996-02-10
US5496809A (en) 1996-03-05
HU206627B (en) 1992-12-28
HK1005033A1 (en) 1998-12-18
DE69016087T2 (de) 1995-05-24
NO902048D0 (no) 1990-05-09
CZ225590A3 (en) 1997-12-17
AU5482390A (en) 1990-11-15
FI902276A0 (fi) 1990-05-07
YU90490A (en) 1991-10-31
GR3015714T3 (en) 1995-07-31
IE66515B1 (en) 1996-01-10
EP0397147A3 (en) 1991-06-12
JPH0317094A (ja) 1991-01-25
EP0397147A2 (en) 1990-11-14
NO176390B (no) 1994-12-19
DE69016087D1 (de) 1995-03-02
DK0397147T3 (da) 1995-03-20
CZ283416B6 (cs) 1998-04-15
EG19218A (en) 1994-10-30
NO902048L (no) 1990-11-12
IE901687L (en) 1990-11-10
PT93991B (pt) 1996-11-29
KR900017596A (ko) 1990-12-19
AU618896B2 (en) 1992-01-09
TW202390B (pt) 1993-03-21
ES2066902T3 (es) 1995-03-16
JPH0643437B2 (ja) 1994-06-08
CN1054510C (zh) 2000-07-19
CA2015632C (en) 1998-01-27
ATE117313T1 (de) 1995-02-15
CA2015632A1 (en) 1990-11-10

Similar Documents

Publication Publication Date Title
ES2064634T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
IS1553B (is) Lyfjaform með langvarandi verkun
FI843286A0 (fi) Stabil, sur vattenloesning av cis-platina laemplig foer injektion.
PT93991A (pt) Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
DK443988D0 (da) Injektionspraeparat indeholdende modificeret tpa
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
JPS5533446A (en) Amino acid transfusion for postoperative patient
DE68900693D1 (de) Pharmazeutische praeparate zur transdermalen applikation von heparin.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960902